Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2007
11/15/2007US20070264262 Adrenoceptor beta 2-mediated diseases such as asthma and chronic obstructive pulmonary disease (COPD); N-(4-tert-butylbenzyl)-4-{[({3-[(2R)-2-(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl) phenyl]ethyl}amino)propyl]phenyl}acetyl)amino]methy} benzamide
11/15/2007US20070264261 Methods of Therapy and Diagnosis Using Targeting of Cells that Express Killer Cell Immunoglobulin like Receptor like Proteins
11/15/2007US20070264260 Treatment methods using anti-CD22 antibodies
11/15/2007US20070264259 Methods for treating kidney disorders
11/15/2007US20070264257 Immunotherapy of autoimmune disorders
11/15/2007US20070264256 polynucleotide sequence of a NTHi, polypeptides encoded by it and antibodies that bind to the polypeptide; detecting NTHi bacteria in a biological sample by contacting a polynucleotide to detect hybridization of the polynucleotide
11/15/2007US20070264255 Antibodies to TGF-beta
11/15/2007US20070264254 Cardiac muscle function and manipulation
11/15/2007US20070264253 Human Anti-Epidermal Growth Factor Receptor Antibody
11/15/2007US20070264252 Modulators of Ms4a Gene Products
11/15/2007US20070264244 Pigment epithelial cell of the eye, its production and use in therapy of an eye or CNS disease
11/15/2007US20070264243 Reversibly immortalized hepatocytes and methods of use
11/15/2007US20070264242 modified non-small cell lung cancer (NSCLC) cells or small cell lung cancer (SCLC) cells; Transforming Growth Factors- beta s (TGF beta s); Gene therapy for antagonizing a transforming growth factors-beta; anticarcinogenic agents
11/15/2007US20070264240 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation
11/15/2007US20070264237 Use of Il-18 Binding Protein in Inflammations
11/15/2007US20070264233 Francisella Strain for Live Vaccine
11/15/2007US20070264232 Cell populations which co-express CD49c and CD90
11/15/2007US20070264231 Tumor-Homing Cells Engineered to Produce Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (Trail) by Adenoviral-Mediated Gene Transfer
11/15/2007US20070264230 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
11/15/2007US20070264229 Peptides for Treatment of Autoimmune Disease
11/15/2007US20070264197 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection reagents
11/15/2007US20070264195 Modulation of Activity of Neurotrophins
11/15/2007US20070264193 Diagnostics and treatments for tumors
11/15/2007CA2653748A1 Non-natural amino acid substituted polypeptides
11/15/2007CA2651194A1 Methods for treating neovascular diseases
11/15/2007CA2650953A1 Combination of an anti edb fibronectin domain antibody l19-sip and an anti-egfr antibody
11/15/2007CA2650718A1 Methods for the treatment of muscular dystrophy associated with dysferlin-deficiency
11/15/2007CA2650580A1 A method for delivering a human chorionic gonadotropin (hcg) vaccine for long-acting antibody production
11/15/2007CA2649962A1 Hcv coreceptor and methods of use thereof
11/15/2007CA2649872A1 Trail receptor-binding agents and uses of the same
11/15/2007CA2648947A1 Therapy targeting cathepsin s
11/15/2007CA2638785A1 Anti-ephb4 antibodies and methods using same
11/14/2007EP1854886A2 Cold-adapted equine influenza viruses
11/14/2007EP1854885A2 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/14/2007EP1854884A2 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
11/14/2007EP1854809A1 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
11/14/2007EP1854808A2 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
11/14/2007EP1854485A1 Preventives/remedies for cancer
11/14/2007EP1854481A2 Cerebral stroke/cerebral edema preventive or remedy containing IL-8 binding inhibitor as active ingredient
11/14/2007EP1854480A2 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
11/14/2007EP1854479A2 Recombinant or purified polyclonal antibodies for treating allergy
11/14/2007EP1854478A1 Nicotine-carrier vaccine formulation
11/14/2007EP1854473A1 Preventive/therapeutic agent for cancer
11/14/2007EP1854472A1 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same
11/14/2007EP1853623A1 Animal product free system and process for purifying a botulinum toxin
11/14/2007EP1853622A1 Media for clostridium bacterium and processes for obtaining a clostridial toxin
11/14/2007EP1853313A2 Humanized l243 antibodies
11/14/2007EP1853312A2 Methods and compositions for modulating tweak and fn14 activity
11/14/2007EP1853311A2 Use of parasitic biological agents for prevention and control of allergic and other ige-mediated disorders
11/14/2007EP1853310A2 Anti a beta antibody formulation
11/14/2007EP1853309A2 Bispecific binding agents for modulating biological activity
11/14/2007EP1853308A1 Pharmaceutical preparation that can be administered orally for treating fish, production method for said preparation and use of the latter
11/14/2007EP1853307A1 Papillomavirus l2 n-terminal peptides for the induction of broadly cross-neutralizing antibodies
11/14/2007EP1853306A2 Polypeptides from staphylococcus aureus and methods of use
11/14/2007EP1853305A2 Survivin peptide vaccine
11/14/2007EP1853294A2 Anti-angiogenic compounds
11/14/2007EP1853227A1 Pharmaceutical composition
11/14/2007EP1565212B1 Gastrin compositions and formulations, and methods of use and preparation
11/14/2007EP1468022B1 Novel monoclonal antibody and nematode larval antigens
11/14/2007EP1425301B1 Therapeutic vaccine mixture for preventing and treating disorders in mammals
11/14/2007EP1423012B1 Medical use of stem cells expressing vegfr-1
11/14/2007EP1411064B1 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
11/14/2007EP1387698B1 Method of preventing cell death using antibodies to neural thread proteins
11/14/2007EP1361895B1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/14/2007EP1354034B1 Transgenic transchromosomal rodents for making human antibodies
11/14/2007EP1322666B1 Hiv peptides from tat,rev and wef conserved regions and their application as e.gvacine compnents
11/14/2007EP1322655B1 Oligodeoxynucleotide and its use to induce an immune response
11/14/2007EP1309860B1 Method for screening peptides for use in immunotherapy
11/14/2007EP1235592B1 Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicament
11/14/2007EP1212086B1 Immunological tolerance-induction agent
11/14/2007EP1210462B1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications
11/14/2007EP1141079B1 Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties
11/14/2007EP1121454B1 Extracellular novel rage binding protein (en-rage) and uses thereof
11/14/2007EP1117435B1 Mutant cholera holotoxin as an adjuvant
11/14/2007EP1114156B1 Mammalian transforming growth factor beta - 9 (ztgfss9)
11/14/2007EP1091735B1 Improved enriched platelet wound healant
11/14/2007EP1053011B1 Mixed micellar pharmaceutical delivery system and method of preparation
11/14/2007EP1003783B1 Lipoprotein-regulating medicaments
11/14/2007EP0960937B1 Novel semaphorin gene: semaphorin y
11/14/2007CN101072875A Novel cancer antigen peptide and the use thereof
11/14/2007CN101072797A Polypeptide compounds for inhibiting angiogenesis and tumor growth
11/14/2007CN101072795A Human monoclonal antibodies to influenza m2 protein and methods of making and using same
11/14/2007CN101072587A Anti-cd154 antibodies
11/14/2007CN101072586A Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
11/14/2007CN101072585A Combination approaches for generating immune responses
11/14/2007CN101072584A Methods and compositions for needleless delivery of macromolecules
11/14/2007CN101072583A Iontophoretic device and method for administering immune response-enhancing agents and compositions
11/14/2007CN101072582A Alpha thymosin peptides as cancer vaccine adjuvants
11/14/2007CN101072581A Therapeutic agents with decreased toxicity
11/14/2007CN101072580A Antibody production method
11/14/2007CN101070541A Gene engineering antibody of resisting chicken newcastle disease virus
11/14/2007CN101070536A Inducing expression of hepatitis-B virus cytomembrane small-protein and middle-protein gene in clover
11/14/2007CN101070348A O-type foot-and-mouth disease virus multi-epitope mucous membrane immunization vaccine and use
11/14/2007CN101070344A G-csf receptor agonist antibodies and screening method therefor
11/14/2007CN101069744A 流感疫苗组合物 Influenza vaccine composition
11/14/2007CN101069743A Use of inactive BCG vaccine in preparation of use for treatment of allergic action diseases
11/14/2007CN101069696A Method for preparing health-care product of oral enteric soluble foremilk immunoglobulin
11/14/2007CN100348268C Method for preparing carbonized resin DNA immunoadsorbent
11/14/2007CN100348266C Peptide antagonists of zonulin and methods for use of the same
11/13/2007US7294753 Method for preparing anti-MIF antibodies
1 ... 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 ... 1823